[Vaginal cytological studies on the new delayed-action estrogen-ethinylestradiol sulfonate].
The colpocytologic efficacy of a new estrogen - ethinylestradiolsulfonate - has been studied in postmenopausal and fertile women. According to the depot character of the compound, ranging between ethinylestradiol and quinestrol, it exhibits a high and prolonged proliferative effect on the atropich vaginal epithelia. The weekly application of 1 mg of the substance in a contraceptive regimen causes a high grade of maturation with considerable individual differences. A single dose of 1 mg ethinylestradiolsulfonate quickly influences conditions of estrogen difficiency in the vaginal epithelia.
D003276:Contraceptives, Oral / Q000494:pharmacology; D003692:Delayed-Action Preparations; D004847:Epithelial Cells; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D014621:Vagina / Q000166:cytology / Q000187:drug effects*; D014626:Vaginal Smears
D003276:Contraceptives, Oral; D003692:Delayed-Action Preparations; D004997:Ethinyl Estradiol
Vaginalzytologische Untersuchungen zum neuen Depot-Ostrogen-Athinylöstradiolsulfonat